Posters

EXPLORE OUR SCIENTIFIC RESOURCES

Get our newsletters

Published on the 16 September 2025

POSTER: “Pro-healing effects of Plasana One®, an argon-generated cold plasma on ischemic skin wounds”

Discover the excellent results on ischemic skin wounds in our Poster: "Pro-healing effects of Plasana One®, an argon-generated cold plasma on ischemic skin wounds”. Presented by Jean-François Bisson a…
Published on the 4 July 2025

POSTER: Behavioural assessment as a tool for evaluation of efficacy therapies on skin diseases

Dr Jean-François BISSON, PhD, and Lianna RAZAFITRIMO, presented the team’s research during the SPIN 2025 (Congress of the Skin Inflammation & Psoriasis International Network) in the poster: "Beha…
Published on the 13 June 2025

POSTER: High-throughput Brain-on-Chip for neurogenerative diseases

Dr Valentin TALLANDIER, in vitro Preclinical Project Leader, presented the team’s research during the MPS World Summit 2025 in Brussels in his poster. Learn more about our high-thoughput capa…
Published on the 19 May 2025

POSTER: “NEUROINFLAMMATION MODELS OF NEURODEGENERATIVE DISEASES”

Dr Ahmad Allouche, Head of in vitro biology, presented the team’s research* during at Venusberg Neuroinflammation Meeting 2025 in Luxembourg in his poster “NEUROINFLAMMATION MODELS OF NEURODEGENERATIV…
Published on the 4 April 2025

POSTER: “ADVANCING ALZHEIMER’S DISEASE MODELS FOR PRECLINICAL DRUG TESTING”

Dr Ahmad Allouche, Head of in vitro biology, presented the team's research* during AD/PD 2025 in Vienna in his poster "ADVANCING ALZHEIMER'S DISEASE MODELS FOR PRECLINICAL DRUG TESTING". Learn more a…
Published on the 8 February 2025

POSTER: “Translational Relevance and Versatility of the Thromboembolic Stroke Model in Mice: Implications for Pharmacological and Safety Evaluations”

Dr Annelise LETOURNEUR, Director of Operations at STROK@LLIANCE and Neuroscience Study Director, presented the team's research* during the American Heart Association’s annual International Stroke Conf…
Published on the 31 July 2024

POSTER: “Effect of SGLT2i on RV failure: comparison between Empagliflozin and current therapies in a preclinical model of RV dysfunction PAH-induced”

Presented by Christophe Muller at the Heart Failure Drug Discovery & Development Summit (in July-August 2024, in Boston, USA, MA). EASY POSTER REQUEST Authors: Guillaume Bourdier1, Jess…